Clinical Trials in Tennessee

Showing 12701-12720 of 20,239 trials

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

NCT03303170

Prospective, randomized, controlled, parallel group clinical study with blinded assessment evaluating Sebacia Microparticles (SM) with Nd:Yag laser in facial inflammatory acne vulgaris

Acne Vulgaris

Sebacia, Inc.168 participantsStarted Sep 2017

Scottsdale, Arizona, United States • San Diego, California, United States • Miami, Florida, United States +8 more locations

COMPLETEDPhase 229 miles

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

NCT02637557

The objectives of this study are to evaluate the safety, efficacy, and dose-response relationship of IW-3718 administered orally to participants who have GERD and continue to experience GERD symptoms while receiving once-daily (QD), standard-dose proton pump inhibitors (PPIs).

Gastroesophageal Reflux Disease

Ironwood Pharmaceuticals, Inc.282 participantsStarted Mar 2016

Dothan, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +59 more locations

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Find Trials by Condition in Tennessee

Humanitarian Device Exemption

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Trial of IMO-8400 in Adult Patients With Dermatomyositis

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

e-NOBORI Observational Registry of Nobori DES